Old Web
English
Sign In
Acemap
>
authorDetail
>
H. Coppens
H. Coppens
Novartis
Medicine
Breast cancer
Aminoglutethimide
General surgery
Internal medicine
4
Papers
47
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Pharmacokinetics of oxiracetam in elderly patients after 800 mg oral doses, comparison with non-geriatric healthy subjects
1990
European Journal of Drug Metabolism and Pharmacokinetics
J B Lecaillon
J. P. Dubois
H. Coppens
T. Darragon
W. Theobald
G. Reumond
H. Beck
Show All
Source
Cite
Save
Citations (7)
Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose
1990
European Journal of Drug Metabolism and Pharmacokinetics
J B Lecaillon
J. P. Dubois
H. Coppens
T. Darragon
G. Reumond
N. Pozet
J. Traeger
G. Lambrey
Show All
Source
Cite
Save
Citations (3)
Aminoglutethimide in advanced breast cancer. Multicenter trial comparing 500 mg and 1000 mg per day
1986
J. Bonneterre
H. Coppens
Mauriac L
Rouëssé J
P. Fargeot
R. Metz
Jean-Pierre Armand
Mathieu A
Tubiana M
P. Cappelaere
Show All
Source
Cite
Save
Citations (0)
Aminoglutethimide in advanced breast cancer: Clinical results of a French multicenter randomized trial comparing 500 mg and 1 g/day
1985
European Journal of Cancer and Clinical Oncology
J. Bonneterre
H. Coppens
Mauriac L
M. Metz
Rouëssé J
Jean-Pierre Armand
P. Fargeot
M Mathieu
Tubiana M
P. Cappelaere
Show All
Source
Cite
Save
Citations (37)
1